Remove 2000 Remove Clinical Trials Remove Conditions
article thumbnail

Knowde Group Inc.™ Enters Into a Strategic Partnership with LMC Manna Research to Drive Quality and Collaboration in the Conduct of Cannabis and Psychedelic Clinical Trials.

Cannabis Law Report

There is an urgent need for objective, scientifically sound and robust clinical trials to support medicinal cannabis and psychedelics (psilocybin, MDMA, LSD, Ketamine). Collectively, between the two organizations we offer a full-service package from protocol development to timely and successful clinical trial execution.”.

article thumbnail

Dr. Andrew Weil on Cannabis and Integrative Medicine

Project CBD

He is the author of several bestselling books, including Spontaneous Healing (1995), Eating Well for Optimum Health (2000), and Healthy Aging (2007). And then cannabis has unique effects for a wide range of conditions, everything from the treatment of pain, treatment of asthma, treatment of immune conditions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Which States Are Voting on Psychedelics?

Veriheal

Johns Hopkins University first received regulatory approval for psychedelic research in the year 2000. The state bill would start the process of legalizing centers for veterans and first responders to receive psilocybin and MDMA (a synthetic psychedelic) to treat mental health conditions like PTSD. Missouri Rep.

article thumbnail

Relief the Natural Way: CBD Oil for Stress and Anxiety

Otherside Farms

Over 700 years later, between 2000 and 1000 BC, cannabis was noted in many Hindu and other religious texts in the area as a “source of happiness” and smoked in daily religious ceremonies and rituals. Fast forward over 2000 years to 1992.

Oil
article thumbnail

Anebulo Pharmaceuticals Names Biotechnology Industry Executive Simon Allen as CEO and Director

Cannabis Law Report

“I am so very proud of all Anebulo has achieved over the past 18 months, including building out a highly effective team, securing new intellectual property protection, preparing and starting a proof-of-concept clinical trial, advancing regulatory discussions with the U.S. and Australia. Anebulo Pharmaceuticals, Inc. Rex Merchant.

article thumbnail

A New Treatment: CBD Oil For Autism?

Puff Puff Post

With so many people affected by autism and incidence rates having increased by 119% between the years 2000 to 2010, it has gained the status of the quickest-growing developmental disability. They aren’t geared towards treating the condition specifically, and rather focus on reducing side-effects from the disorder like anxiety and insomnia.

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. We also used manifest textual analysis to search for word frequencies, and specific conditions referred to in the articles retrieved. Spasticity from neurological conditions. Background. Conclusions. Bonini et al.